Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Pantel

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
p53 gene mutations are not required for early dissemination of cancer cellsS Offner, W Schmaus, K Witter, et al.
BJU International|November 25, 2003
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerM G Friedrich, M I Toma, A Hellstern, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cellsB Passlick, K Pantel, B Kubuschok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrowA Zippelius, P Kufer, G Honold, et al.
Cancer Research|March 1, 1993
Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancerK Pantel, J R Izbicki, M Angstwurm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patientsS Braun, C Kentenich, W Janni, et al.
Urologic Oncology|June 9, 2018
Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy."A Soave, S Riethdorf, R Dahlem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrowS Braun, F Hepp, C R Kentenich, et al.
The International Journal of Biological Markers|October 3, 2006
Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancerI Witzel, C Thomssen, S Krenkel, et al.
Urological Research|January 1, 1994
Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancerR Oberneder, R Riesenberg, M Kriegmair, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
p53 gene mutations are not required for early dissemination of cancer cellsS Offner, W Schmaus, K Witter, et al.
BJU International|November 25, 2003
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerM G Friedrich, M I Toma, A Hellstern, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cellsB Passlick, K Pantel, B Kubuschok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrowA Zippelius, P Kufer, G Honold, et al.
Cancer Research|March 1, 1993
Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancerK Pantel, J R Izbicki, M Angstwurm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patientsS Braun, C Kentenich, W Janni, et al.
Urologic Oncology|June 9, 2018
Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy."A Soave, S Riethdorf, R Dahlem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrowS Braun, F Hepp, C R Kentenich, et al.
The International Journal of Biological Markers|October 3, 2006
Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancerI Witzel, C Thomssen, S Krenkel, et al.
Urological Research|January 1, 1994
Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancerR Oberneder, R Riesenberg, M Kriegmair, et al.
Pageof 16